Results 181 to 190 of about 176,568 (258)

Exploring the role of the key gene TNFAIP3 between periodontitis and influenza A through bioinformatic analysis and molecular docking. [PDF]

PLoS One
Xu M, Shi J, Wang Y, Wu J, Yang Q, Chen W, Li Y, Zhang L, Liu X, Ren F, Wu Y, Ye L, Li X, Xu K.   +13 more
europepmc   +1 more source

A Monoclonal Antibody ELISA–Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background The single radial immunodiffusion (SRID) assay is used to determine the potency of inactivated influenza vaccines. Nevertheless, development of alternative influenza vaccine potency assays with greater sensitivity and less reliance on large quantities of reference reagents is needed.
Marcus Odin, Falko Schmeisser, Jackeline Soto, Jerry P. Weir   +3 more
wiley   +1 more source

The 2009 H1N1 Swine Flu Pandemic: Reconciling Goals of Patents and Public Health Initiatives [PDF]

, 2010
Kaplan, Michelle
core   +1 more source

The CD97-PPM1G axis dampens antiviral immunity by dephosphorylating IRF7 in type I interferon pathway. [PDF]

PLoS Pathog
Chang H, Qi W, Yang R, Hou P, Kang R, Liu X, Li Y, Wang H, He H.   +8 more
europepmc   +1 more source

Strain Agnostic Influenza Virus Propagation in a Serum‐Free, Suspension‐Adapted MDCK Cell Line

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background The continuing circulation and evolution of seasonal influenza viruses remains a public health and socioeconomic threat on a global scale. Viral surveillance and vaccination of the public have been relied upon to confer and boost immunity in the population. Traditionally, influenza strains are propagated in embryonated chicken eggs,
Jessica B. Huskey, Michelle L. Rock, Pooja V. Chaudhary, Emily C. Hill, Madeline E. Hoover, Nicole M. Rideout, Kamerin D. Dean, Thomas Scott Alderman, Phong Ho, M. Anthony Moody, Gregory D. Sempowski, Thomas H. Oguin III   +11 more
wiley   +1 more source

Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background Quantifying the burden of respiratory syncytial virus (RSV) in adults is challenging compared to influenza, and data among older adults remain scarce in Japan. Country‐specific evidence is essential to support RSV vaccination policy.
Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel, Yuka Fujita, Yuji Akiba, Yutaka Nishigaki, Kei Nakashima, Hiroyuki Ito, Masayuki Nogi, Yoshihito Otsuka, Masayuki Ishida, Eiji Takeuchi, Norichika Asoh, Toyomitsu Sawai, Koichi Hayakawa, Eileen M. Dunne, Claudia Schwarz, Bradford D. Gessner, Elizabeth Begier, Shuhei Ito, Ataru Igarashi, Shinobu Osanai, Konosuke Morimoto, Koya Ariyoshi, Adult Pneumonia Study Group‐Japan 2 (APSG‐J2)   +24 more
wiley   +1 more source

UNH Experts Bring Insight To H1N1 Outbreak [PDF]

, 2009
Wright, Lori
core   +1 more source

Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost‐Effectiveness Analysis

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background Baloxavir marboxil, an antiviral used only in private hospitals in Hong Kong since February 2019 for treating influenza, is recognized for its efficacy against strains resistant to standard antiviral agents, providing an alternative to neuraminidase inhibitors such as oseltamivir.
Ruohan Chen, Zengyang Shao, Kaiming Bi, Benjamin John Cowling, Zhanwei Du   +4 more
wiley   +1 more source

Hospitalized children with influenza virus: a 17 year-long observational study including the 2009 H1N1 influenza pandemic and COVID-19 pandemic. [PDF]

BMC Infect Dis
Jalving HT, Christensen A, Nordbø SA, Risnes K, Døllner H, Heimdal I.   +5 more
europepmc   +1 more source

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09‐Associated Hospitalizations With SARI in Beijing, China, in the 2024–2025 Season

Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.
ABSTRACT Background In the 2024–2025 season, influenza activity returned to pre‐COVID‐19 pandemic levels, with A(H1N1)pdm09 as the predominant subtype. Reassessment vaccine effectiveness (VE) in hospitalized patients is critical to inform potential adjustments to vaccination policy.
Chunna Ma, Ying Sun, Jiaxin Ma, Yingying Wang, Xiaodi Hu, Ying Shen, Li Zhang, Jiaojiao Zhang, Lu Zhang, Wei Duan, Jia Li, Quanyi Wang, Daitao Zhang, Peng Yang   +13 more
wiley   +1 more source